BDT — Biodit AD Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End null | Unit | null | null | null | null | null | nullE | nullE | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Biodit AD, formerly Biodit Global Technology AD is a Bulgaria-based technology company engaged in software development. The Company specializes in providing biometric security solutions tailored specifically for the hospitality industry. The Company offers a comprehensive hotel management system that includes a variety of features, such as: real-time monitoring of guest and staff movements, access control using personal cards, mobile keys, or physical keys, integration with Property Management Systems (PMS) systems for seamless reservation management, energy management for optimizing electricity usage in rooms, as well as staff management tools for creating work schedules and tracking working hours.
Directors
- Last Annual
- Last Interim
- Incorporated
- January 5th, 2016
- Public Since
- March 4th, 2021
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
- Bulgarian Stock Exchange
- Address
- 125 Kliment Ohridski blv., SOFIA, 1756
- Web
- https://www.biodit.com
- Phone
- Auditors
Similar to BDT
Boleron AD
Bulgarian Stock Exchange
Investor.bg AD
Bulgarian Stock Exchange
Sirma Holding AD
Bulgarian Stock Exchange
Web Media AD
Bulgarian Stock Exchange
Wiser Technology AD
Bulgarian Stock Exchange
FAQ
As of Today at 19:35 UTC, shares in Biodit AD are trading at BGN0.37. This share price information is delayed by 15 minutes.
Shares in Biodit AD last closed at BGN0.37 and the price had moved by -66.36% over the past 365 days. In terms of relative price strength the Biodit AD share price has underperformed the FTSE Global All Cap Index by -67.21% over the past year.
There is no consensus recommendation for this security.
Find out moreBiodit AD does not currently pay a dividend.
Biodit AD does not currently pay a dividend.
Biodit AD does not currently pay a dividend.
To buy shares in Biodit AD you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of BGN0.37, shares in Biodit AD had a market capitalisation of .
Here are the trading details for Biodit AD:
- Country of listing: Bulgaria
- Exchange: BLG
- Ticker Symbol: BDT
Based on an overall assessment of its quality, value and momentum Biodit AD is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biodit AD. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -58.94%.
As of the last closing price of BGN0.37, shares in Biodit AD were trading -63.72% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Biodit AD PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at BGN0.37.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Biodit AD's directors